These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12716496)

  • 1. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer.
    Nonnenmacher B; Pintos J; Bozzetti MC; Mielzinska-Lohnas I; Lorincz AT; Ikuta N; Schwartsmann G; Villa LL; Schiller JT; Franco E
    Int J STD AIDS; 2003 Apr; 14(4):258-65. PubMed ID: 12716496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
    Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
    J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
    Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
    J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.
    Clifford GM; Shin HR; Oh JK; Waterboer T; Ju YH; Vaccarella S; Quint W; Pawlita M; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1874-9. PubMed ID: 17855708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.
    Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
    Cancer Detect Prev; 1995; 19(5):381-93. PubMed ID: 7585724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions.
    Hagensee ME; Koutsky LA; Lee SK; Grubert T; Kuypers J; Kiviat NB; Galloway DA
    J Infect Dis; 2000 Apr; 181(4):1234-9. PubMed ID: 10753726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile.
    Ferreccio C; Prado RB; Luzoro AV; Ampuero SL; Snijders PJ; Meijer CJ; Vaccarella SV; Jara AT; Puschel KI; Robles SC; Herrero R; Franceschi SF; Ojeda JM
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2271-6. PubMed ID: 15598792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
    Sun CA; Hsiung CA; Lai CH; Chen CA; Chou CY; Ho CM; Twu NF; Feng WL; Chuang MH; Hsieh CY; Chu TY
    J Med Virol; 2005 Oct; 77(2):273-81. PubMed ID: 16121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of vaginal human papillomavirus infection in hysterectomized women.
    Castle PE; Schiffman M; Bratti MC; Hildesheim A; Herrero R; Hutchinson ML; Rodriguez AC; Wacholder S; Sherman ME; Kendall H; Viscidi RP; Jeronimo J; Schussler JE; Burk RD
    J Infect Dis; 2004 Aug; 190(3):458-67. PubMed ID: 15243917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-variable L1-peptide displays high sensitivity and specificity for detecting women having human papillomavirus-associated cervical lesions.
    Urquiza M; Guevara T; Sanchez R; Vanegas M; Patarroyo ME
    Peptides; 2008 Jun; 29(6):957-62. PubMed ID: 18294733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.